McIntyre Barry S, Barlow Norman J, Foster Paul M D
CIIT Centers for Health Research, P. O. Box 12137, Research Triangle Park, North Carolina 27709-2137, USA.
Toxicol Sci. 2002 Jan;65(1):62-70. doi: 10.1093/toxsci/65.1.62.
Prenatal exposure to the herbicide linuron, a weak androgen receptor antagonist, has been shown to perturb androgen-dependent male rat reproductive development as evidenced by slight decreases in anogenital distance (AGD), increased retention of areolae/nipples, and induction of epididymal malformations in combination with testicular atrophy in the adult rat over dose levels ranging from 12.5 to 100 mg/kg/day. Studies were undertaken to determine whether linuron-mediated changes in AGD and nipple retention are permanent, whether linuron is a direct testicular toxicant, and if there was an association between areola/nipple retention and malformations. Pregnant rats were administered corn oil vehicle or linuron by gavage at 0 or 50 mg/kg/day (n = 8 controls, 20 treated) from gestation days 12 to 21. Male offspring were necropsied on postnatal days (PND) 35 and 56. Linuron-exposed male rats exhibited a significant (8%) decrease in AGD on PND 1 and a similar decrease was also observed on PND 56. Linuron-exposed male rats displayed an increase in areola retention on PND 13, as evidenced by 0.6 +/- 0.5 and 3.3 +/- 0.4 areolae per rat in the control and exposed groups, respectively. Male rats displayed a significant increase in nipple retention on PND 35 and 56 (collectively) of 0 +/- 0.5 and 1.7 +/- 0.3 nipples per rat in control and exposed groups, respectively. On PND 35, 4/51 rats (3/9 litters) from linuron-treated dams displayed enlarged testes in combination with malformed epididymides. Epididymal malformations were observed in 19/51 rats (6/9 litters) in the linuron-exposed dose group. On PND 56, grossly enlarged and edematous testes were seen in 16/56 linuron-exposed rats (6/9 litters). Epididymal lesions were observed in 23/58 rats (6/9 litters). Microscopically, all linuron-exposed animals that exhibited a testicular lesion on PND 56 also displayed an epididymal lesion. These lesions were not seen in control animals. Approximately 25 and 60% of the male offspring that had malformations of the epididymis and vas deferens did not exhibit either areolae on PND 13 or nipples at necropsy, respectively. These data indicate that in utero linuron exposure to 50 mg/kg/day results in permanent changes in AGD and nipple retention in male rats. Moreover, these findings indicate that linuron-induced testicular atrophy, which is observed in adult rats, is secondary to increased intratubular pressure resulting from obstruction of testicular fluid outflow subsequent to malformation of the epididymides. These data also suggest that although linuron-mediated retention of areolae on PND 13 and nipples at necropsy may be suggestive of altered testosterone-mediated reproductive development seen in adult rats, these endpoints are not predictive.
产前接触除草剂利谷隆(一种弱雄激素受体拮抗剂)已被证明会干扰雄激素依赖的雄性大鼠生殖发育,在成年大鼠中,剂量范围为12.5至100毫克/千克/天,表现为肛门生殖器距离(AGD)略有缩短、乳晕/乳头保留增加以及附睾畸形合并睾丸萎缩。开展了多项研究,以确定利谷隆介导的AGD和乳头保留变化是否是永久性的,利谷隆是否是直接的睾丸毒物,以及乳晕/乳头保留与畸形之间是否存在关联。从妊娠第12天至21天,给怀孕大鼠经口灌胃玉米油载体或利谷隆,剂量为0或50毫克/千克/天(n = 8只对照,20只处理)。雄性后代在出生后第35天和第56天进行尸检。接触利谷隆的雄性大鼠在出生后第1天AGD显著降低(8%),在出生后第56天也观察到类似程度的降低。接触利谷隆的雄性大鼠在出生后第13天乳晕保留增加,对照组和接触组每只大鼠的乳晕分别为0.6±0.5个和3.3±0.4个。雄性大鼠在出生后第35天和第56天(总体)乳头保留显著增加,对照组和接触组每只大鼠的乳头分别为0±0.5个和1.7±0.3个。在出生后第35天,来自经利谷隆处理的母鼠的51只大鼠中有4只(9窝中的3窝)睾丸肿大并伴有附睾畸形。在接触利谷隆的剂量组中,51只大鼠中有19只(9窝中的6窝)观察到附睾畸形。在出生后第56天,16只接触利谷隆的大鼠(9窝中的6窝)可见明显肿大和水肿的睾丸。58只大鼠中有23只(9窝中的6窝)观察到附睾病变。显微镜下,所有在出生后第56天出现睾丸病变的接触利谷隆的动物也都有附睾病变。对照动物未出现这些病变。分别约25%和60%附睾和输精管畸形的雄性后代在出生后第13天未出现乳晕或尸检时未出现乳头。这些数据表明,子宫内接触50毫克/千克/天的利谷隆会导致雄性大鼠AGD和乳头保留的永久性变化。此外,这些发现表明,成年大鼠中观察到的利谷隆诱导的睾丸萎缩是附睾畸形后睾丸液流出受阻导致管内压力增加的继发结果。这些数据还表明,尽管利谷隆介导的出生后第13天乳晕保留和尸检时乳头保留可能提示成年大鼠中睾酮介导的生殖发育改变,但这些指标并无预测性。